SAN FRANCISCO, Nov. 30, 2022 /PRNewswire/ -- Vial, a faster, better, cheaper CRO powered by technology, announced today that they have raised over $100M in cumulative equity funding since ...

SAN FRANCISCO, June 11, 2023 /PRNewswire/ -- Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be presenting at the 2023 Life Sciences ...

Vial, like many in the CRO field, has been working to change how clinical trials are conducted following the COVID-19 pandemic and the widespread adoption of new digital technology.

SAN FRANCISCO, Aug. 6, 2023 /PRNewswire/ -- Vial, a global tech-driven CRO providing next-generation clinical trial management services, announced the addition of Emma C. Moran to their team ...

SAN FRANCISCO, June 1, 2022 /PRNewswire/ -- Vial has announced that they will be expanding their CRO into Oncology. This exciting announcement comes after their successful launches in Dermatology ...

CRO startup Vial, which focuses on offering clinical trial services to the biotech industry, reeled in $67 million in series B funding it plans to use to further its global expansion.

SAN FRANCISCO, Nov. 30, 2022 /PRNewswire/ -- Vial, a faster, better, cheaper CRO powered by technology, announced today that they have raised over $100M in cumulative equity funding since ...

SAN FRANCISCO, June 11, 2023 /PRNewswire/ -- Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be presenting at the 2023 Life Sciences ...

SAN FRANCISCO, Nov. 30, 2022 /PRNewswire/ -- Vial, a faster, better, cheaper CRO powered by technology, announced today that they have raised over $100M in cumulative equity funding since ...